Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Vincent Mulkern, Ph.D.

Co-Author

This page shows the publications co-authored by Robert Mulkern and Fiona Fennessy.
Connection Strength

1.951
  1. Practical considerations in T1 mapping of prostate for dynamic contrast enhancement pharmacokinetic analyses. Magn Reson Imaging. 2012 Nov; 30(9):1224-33.
    View in: PubMed
    Score: 0.529
  2. Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer-A Pilot Study. Acad Radiol. 2020 10; 27(10):1432-1439.
    View in: PubMed
    Score: 0.220
  3. Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer. Abdom Radiol (NY). 2018 05; 43(5):1237-1244.
    View in: PubMed
    Score: 0.196
  4. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology. Abdom Radiol (NY). 2017 03; 42(3):918-925.
    View in: PubMed
    Score: 0.181
  5. Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) model. NMR Biomed. 2016 07; 29(7):999-1009.
    View in: PubMed
    Score: 0.172
  6. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging. 2015 Sep; 33(7):886-94.
    View in: PubMed
    Score: 0.157
  7. The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI. Acad Radiol. 2015 May; 22(5):548-55.
    View in: PubMed
    Score: 0.157
  8. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation. Magn Reson Imaging. 2014 May; 32(4):321-9.
    View in: PubMed
    Score: 0.146
  9. Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study. Magn Reson Med. 2018 05; 79(5):2564-2575.
    View in: PubMed
    Score: 0.047
  10. Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence. Magn Reson Imaging. 2015 Jun; 33(5):525-30.
    View in: PubMed
    Score: 0.039
  11. Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. Radiology. 2015 Jan; 274(1):170-80.
    View in: PubMed
    Score: 0.038
  12. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013 May; 37(5):1035-54.
    View in: PubMed
    Score: 0.035
  13. Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):e101-7.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.